BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing...
Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from...
Members will learn how to manage symptoms, get practical strategies to thrive and hear inspiring stories of personal experiences—including from...
Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) ClearanceIntroduces 'Neurophet AQUA AD,' a Total Solution for Alzheimer's Disease Treatment Prescription,...
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion LeadersCompany committed to addressing the most aggressive type of...
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy for quicker patient liberation from mechanical ventilationEXTON, Pa., Dec. 05,...
ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed...
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing...
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the...
70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination...
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or...
AI Powers the Fight Against ALS LAS VEGAS, Dec. 4, 2024 /PRNewswire/ --A partnership between Compass UOL, an AI transformation...
Wake Forest Institute for Regenerative Medicine and BMI OrganBank are Key Partners in Stanford-Led Consortium to Advance Vision-Restoring Transplants WINSTON-SALEM,...
TORONTO, Dec. 4, 2024 /CNW/ - Following a competitive, nationwide call for proposals, AGE-WELL is pleased to announce funding for nine...
GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today...
GAINESVILLE, Fla., Dec. 4, 2024 /PRNewswire/ -- Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today...
Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort...
EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a...
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global in-vitro and...